SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

Abstract Background Many patients with severe asthma continue to experience asthma symptoms and exacerbations despite standard-of-care treatment. A substantial proportion of these patients require long-term treatment with oral corticosteroids (OCS), often at high doses, which are associated with con...

Full description

Bibliographic Details
Main Authors: Michael E. Wechsler, Gene Colice, Janet M. Griffiths, Gun Almqvist, Tor Skärby, Teresa Piechowiak, Primal Kaur, Karin Bowen, Åsa Hellqvist, May Mo, Esther Garcia Gil
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Respiratory Research
Subjects:
Alarmin
Asthma
Asthma control
Exacerbation
Epithelial
Oral corticosteroids
Online Access:http://link.springer.com/article/10.1186/s12931-020-01503-z

Internet

http://link.springer.com/article/10.1186/s12931-020-01503-z

Similar Items